Related Experiment Video
Updated: May 4, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Obesity as an independent risk for left ventricular diastolic dysfunction in 692 Japanese patients
Kinuko Dote, Yoko Miyasaka1, Satoshi Tsujimoto
1Cardiovascular Division, Department of Medicine II, Kansai Medical University, Hirakata, Osaka, Japan.
Insights
Obesity is independently linked to left ventricular (LV) diastolic dysfunction, a key indicator of heart disease risk. This finding highlights the importance of weight management for cardiovascular health.
Area of Science:
- Cardiology
- Obesity Research
- Diagnostic Imaging
Background:
- Obesity and left ventricular (LV) diastolic dysfunction are significant risk factors for cardiovascular morbidity and mortality.
- Limited data exists on the independent association between obesity and LV diastolic dysfunction.
Purpose of the Study:
- To investigate whether obesity is independently associated with LV diastolic dysfunction.
- To assess the risk of abnormal LV diastolic function in relation to Body Mass Index (BMI) categories.
Main Methods:
- Prospective study of 692 adult patients with sinus rhythm undergoing transthoracic echocardiography.
- Exclusion of patients with pre-existing heart conditions or impaired LV systolic function.
- Classification of diastolic function using mitral/pulmonary venous flow and Doppler tissue imaging; BMI categorized as normal, overweight, or obese.
Main Results:
- 78% of patients exhibited abnormal LV diastolic function.
- Obesity (BMI ≥30 kg/m²) was independently associated with LV diastolic dysfunction (OR: 2.98, P=0.03), even after adjusting for cardiovascular risk factors.
- This association remained significant when accounting for LV mass (OR: 2.88, P=0.04); overweight status showed no independent association.
Conclusions:
- Obesity is an independent risk factor for left ventricular diastolic dysfunction.
- The association between obesity and diastolic dysfunction persists irrespective of other cardiovascular risk factors and LV mass.
Background:
Both obesity and left ventricular (LV) diastolic dysfunction are associated with an increased risk of cardiovascular morbidity and mortality. There is a paucity of data as to whether obesity is independently associated with LV diastolic dysfunction.
Methods:
Adult patients with sinus rhythm referred for a transthoracic echocardiography between July, 2007, and December, 2007, were prospectively included. Exclusion criteria were patient who had a history of congenital or valvular heart disease, treatment with pacemaker implantation or implantable cardioverter defibrillator, myocardial infarction, or impaired LV systolic function. Diastolic function was classified by an algorithm incorporating data from mitral and pulmonary venous flow indices, and Doppler tissue imaging. Body mass index (BMI) was evaluated as a categorical variable (normal weight <25.0 kg/m(2); overweight 25.0 to <30.0 kg/m(2); and obese ≥30 kg/m(2)). Logistic models were used to assess the risk of abnormal LV diastolic function associated with BMI categories.
Results:
Of a total number of 692 patients who met all study criteria (mean 59 ± 15 year-old; 50% women, 48% hypertension, 16% diabetes, 26% overweight, 8% obese), 538 (78%) had abnormal LV diastolic function. In multivariate analyses adjusting for age, sex, and cardiovascular risk factors, obesity was independently associated with LV diastolic dysfunction (odds ratio [OR]: 2.98, 95% confidence interval [CI]: 1.12-7.88; P = 0.03) compared to normal weight. LV mass did not weaken this association (OR: 2.88, 95% CI: 1.08-7.68; P = 0.04). Overweight was not independently associated with LV diastolic dysfunction.
Conclusion:
Obesity was associated with LV diastolic dysfunction independent of cardiovascular risk factors and LV mass.
More Related Videos
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
06:34Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Related Concept Videos
Drug Dosing: Obese Patients
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Coronary Artery Disease II: Pathophysiology
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion